Changes in invasive pneumococcal disease among adults living with HIV following introduction of 13-valent pneumococcal conjugate vaccine, 2008–2014

BACKGROUND: People living with HIV (PLHIV) are at increased risk of invasive pneumococcal disease (IPD). Introduction of 13-valent pneumococcal conjugate vaccine (PCV13) in children in 2010 reduced adult IPD burden (indirect effects). In 2012, PCV13 was recommended in series with 23-valent polysacch...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Miwako, Adih, William, Li, Jianmin, Gierke, Ryan, Almendares, Olivia M, Watt, James, Alden, Nisha, Petit, Susan, Farley, Monica, Harrison, Lee, Lynfield, Ruth, Baumbach, Joan, Thomas, Ann, Schaffner, William, Pilishvili, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631992/
http://dx.doi.org/10.1093/ofid/ofx162.134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631992/
http://dx.doi.org/10.1093/ofid/ofx162.134

Ejemplares similares